In Q4 2024, BioHarvest Sciences (BHST) reported a revenue of $282,000, with operating expenses amounting to $2.96 million, resulting in a net loss. The gross profit margin stood at 55.35% for the period1.
| | |
---|
20240101-2024 | Contract Development And Manufacturing Operation Services | 282.00K |
20240101-2024 | Contract Development And Manufacturing Operation Services | 232.00K |
20240101-2024 | Contract Development And Manufacturing Operation Services | 75.00K |
|
---|
BioHarvest SciencesBHST |
BioHarvest SciencesBHST |
BioHarvest SciencesBHST |
View null result
